Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for stomach cancer: enhertu combo takes on tough tumors

NCT ID NCT06731478

Disease control Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 6 times

Summary

This large Phase 3 trial is testing whether a newer targeted drug, trastuzumab deruxtecan (Enhertu), combined with chemotherapy and possibly the immunotherapy pembrolizumab (Keytruda), works better than the current standard treatment for advanced HER2-positive stomach or gastroesophageal junction cancer. About 726 adults who have not yet been treated for their advanced cancer will take part. The study aims to see if the new combination can delay cancer growth and improve survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
trastuzumab deruxtecan (Enhertu) plus chemotherapy, with or without pembrolizumab (Keytruda)
What this could lead to
If successful, this could offer a more effective first-line treatment option for people with advanced HER2-positive stomach cancer, potentially extending life without the disease worsening.
What could go wrong
This is an early-stage Phase 3 trial, so results are not yet known. The new combination may not prove better than current standard therapy, and side effects from the drugs could be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 726 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Sign and date the Tissue Prescreening ICF, prior to central HER2 and PD-L1 CPS testing. Sign and date the Main Screening ICF, prior to the start of any trial-specific qualification procedures. Sign and date the Optional PGx ICF (included in the Main Screening ICF) prior to any PGx procedure. 2. Adults ≥18 years of age on the day of signing the ICF. Follow local regulatory requirements if the legal age of consent for trial participation is \>18 years old. 3. Previously untreated, unresectable, locally advanced or metastatic gastric or GEJ adenocarcinoma histologically confirmed by pathology report. Prior treatment in the perioperative and/or adjuvant setting is permissible, provided there is \>6 months between the end of perioperative or neoadjuvant treatment and the diagnosis of recurrent disease. Note: Prior use of IO (ie, anti-PD-1/PD-L1) therapy in the (neo)adjuvant setting is allowed as long as there is \>6 months between the end of IO therapy and the diagnosis of recurrent disease. 4. Centrally determined HER2-positive (IHC 3+ or IHC 2+/ISH-positive) gastric or GEJ cancer as classified by the American Society of Clinical Oncology-College of American Pathologists for GC on a tumor biopsy as detected by prospective central test on new (core, incisional, excisional biopsy) or existing tumor tissue taken at the time of diagnosis of locally advanced or metastatic disease. Note: Archival samples taken from a previous diagnostic or surgical biopsy not previously irradiated can be accepted. Details pertaining to tumor tissue submission can be found in the Study Laboratory Manual. 5. Centrally determined tumor PD-L1 CPS using the PD-L1 assay: * For the Main Cohort: PD-L1 CPS ≥1 * For the Exploratory Cohort: PD-L1 CPS \<1 6. All participants must provide a tumor sample for tissue-based IHC staining to centrally determine HER2 expression, PD-L1 CPS, and other correlatives. The mandatory FFPE or new biopsy tumor sample can be from either the primary tumor or metastatic biopsy. Specimens with limited tumor content (as centrally determined) and cytology samples are inadequate for defining tumor HER2 and PD-L1 status. 7. At least 1 target measurable lesion on CT or MRI, assessed by the investigator based on RECIST v1.1. Lesions situated in a previously irradiated area are considered measurable if progression has been shown in such lesions. 8. LVEF ≥50% within 28 days before randomization. Exclusion Criteria 1. Prior exposure to other HER2-targeting therapies (including ADCs). 2. Lack of physiological integrity of the upper gastrointestinal tract (ie, severe Crohn disease that results in malabsorption) or malabsorption syndrome that would preclude feasibility of oral chemotherapy for participants planned to be offered capecitabine as part of the study treatment. 3. Known total or partial DPD enzyme deficiency. Note: Screening for DPD enzyme deficiency is required only in regions/countries where DPD testing is SoC and with unknown DPD status. For regions/countries where DPD testing is not SoC, local practice should be followed. In Spain and Italy, screening for DPD enzyme deficiency is mandatory for all participants with unknown DPD status. 4. Contraindications to trastuzumab, 5-FU, capecitabine, cisplatin, or oxaliplatin treatment as per local label. 5. Medical history of myocardial infarction within 6 months before randomization or symptomatic CHF (New York Heart Association Class II to IV). Participants with troponin levels above ULN at Screening (as defined by the manufacturer) and without any myocardial infarction -related symptoms should have a cardiologic consultation during the Screening Period to rule out myocardial infarction. 6. Has a corrected QT interval (QTcF) prolongation to \>470 ms (females) or \>450 ms (males) based on the average of the screening triplicate 12-lead ECG. 7. Has a history of (non-infectious) ILD/pneumonitis that required steroids, has current ILD/pneumonitis, or where suspected ILD/pneumonitis cannot be ruled out by imaging at Screening 8. Lung-specific intercurrent clinically significant illnesses including, but not limited to, any underlying pulmonary disorder (eg, pulmonary emboli within 3 months of the trial randomization, severe asthma, severe chronic obstructive pulmonary disease, restrictive lung disease, pleural effusion, etc).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastric adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric cancer gastric neoplasm gastroesophageal cancer gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastric cancer Gastroesophageal junction cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    244 sites in 26 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • A.O.U. Policlinico di Modena

    RECRUITING

    Modena, Italy

  • AZ Sint-Lucas

    RECRUITING

    Bruges, Belgium

  • Aichi Cancer Center Hospital

    RECRUITING

    Nagoya, Japan

  • Akershus universitetssykehus HF

    RECRUITING

    Lørenskog, Norway

  • Altnagelvin Area Hospital

    RECRUITING

    Londonderry, United Kingdom

  • Anhui Provincial Cancer Hospital

    RECRUITING

    Hefei, China

  • Ankara City Hospital

    NOT_YET_RECRUITING

    Ankara, Turkey (Türkiye)

  • Antoni van Leeuwenhoek

    RECRUITING

    Amsterdam, Netherlands

  • Asan Medical Center

    RECRUITING

    Seoul, 5505, South Korea

  • Ataturk University Medical Faculty

    RECRUITING

    Erzurum, Turkey (Türkiye)

  • Azienda Ospedaliera Card. G. Panico

    RECRUITING

    Tricase, Italy

  • Azienda Ospedaliera Universitaria Careggi

    RECRUITING

    Florenze, Italy

  • Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"

    RECRUITING

    Naples, Italy

  • Azienda Ospedaliero Universitaria Pisana

    RECRUITING

    Pisa, Italy

  • Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino

    RECRUITING

    Torino, Italy

  • Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda)

    RECRUITING

    Milan, Italy

  • Azienda Unità Sanitaria Locale- Ravenna

    RECRUITING

    Ravenna, Italy

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, 100142, China

  • Beskidzkie Centrum Onkologii im.Jana Pawla II

    RECRUITING

    Bielsko-Biala, Poland

  • Biocenter

    RECRUITING

    Concepción, Chile

  • Blue Ridge Cancer Care

    NOT_YET_RECRUITING

    Roanoke, Virginia, 24014, United States

  • CEMIC Ciudad Autonoma

    NOT_YET_RECRUITING

    Buenos Aires, Argentina

  • CEPON - Centro de Pesquisas Oncológicas de Santa Catarina

    RECRUITING

    Florianópolis, Brazil

  • CHA Bundang Medical Center, CHA University

    RECRUITING

    Seongnam-si, South Korea

  • CHU Bordeaux - Hôpital Haut-Lévêque

    RECRUITING

    Pessac, France

  • CHU Grenoble - Hopital Michallon

    RECRUITING

    Grenoble, France

  • CHU Montpellier, Saint Eloi

    RECRUITING

    Montpellier, France

  • CHU Poitiers - Hôpital la Milétrie

    RECRUITING

    Poitiers, France

  • CHU UCL Namur

    RECRUITING

    Namur, Belgium

  • CHU de Brest - Hopital de la Cavale Blanche

    RECRUITING

    Brest, France

  • CHUS - Hôtel-Dieu

    NOT_YET_RECRUITING

    Sherbrooke, Canada

  • Cancer Institute Hospital of JFCR

    RECRUITING

    Kōtoku, 135-8550, Japan

  • Castle Hill Hospital

    RECRUITING

    Hull, United Kingdom

  • Centre Georges François Leclerc

    RECRUITING

    Dijon, France

  • Centre Hospitalier Universitaire de Liege

    RECRUITING

    Liège, Belgium

  • Centre Oscar Lambret

    RECRUITING

    Lille, France

  • Centro de Estudios Clinicos SAGA

    RECRUITING

    Santiago, Chile

  • Centro de Investigacion del Maule

    RECRUITING

    Region Del Maule, Chile

  • Centro de Investigaciones Medicas Mar del Plata

    RECRUITING

    Mar del Plata, Argentina

  • Centro de Oncologia - Unidade Brasilia - Hospital Sirio Libanes

    RECRUITING

    Brasília, Brazil

  • Centrul de Oncologie Sfantul Nectarie Craiova

    RECRUITING

    Craiova, Romania

  • Chang Gung Memorial Hospital,Linkou

    RECRUITING

    Taoyuan City, 333, Taiwan

  • Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

    RECRUITING

    Berlin, Germany

  • Cho Ray Hospital

    NOT_YET_RECRUITING

    Ho Chi Minh City, Vietnam

  • Chonnam National University Hwasun Hospital

    RECRUITING

    Hwasun-gun, 58128, South Korea

  • Chru De Nantes Hotel-Dieu

    RECRUITING

    Nantes, France

  • Chulabhorn Hospital

    RECRUITING

    Laksi, Thailand

  • Chungbuk National University Hospital

    RECRUITING

    Cheongju-si, South Korea

  • Cité de la Santé de Laval

    WITHDRAWN

    Laval, H7M 3L9, Canada

  • Clinica Universitaria Privada Reina Fabiola

    RECRUITING

    Córdoba, Argentina

  • Cliniques Universitaires Saint-Luc

    RECRUITING

    Brussels, Belgium

  • Dicle University, Medical faculty

    RECRUITING

    Diyarbakır, Turkey (Türkiye)

  • Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital

    RECRUITING

    Ankara, Turkey (Türkiye)

  • ETZ Elisabeth

    NOT_YET_RECRUITING

    Tilburg, Netherlands

  • Erasmus Medisch Centrum

    RECRUITING

    Rotterdam, Netherlands

  • FALP - Fundación Arturo López Pérez

    RECRUITING

    Santiago, Chile

  • Fakultni nemocnice Hradec Kralove

    RECRUITING

    Hradec Králové, Czechia

  • Fakultni nemocnice Olomouc

    RECRUITING

    Olomouc, Czechia

  • Fakultni nemocnice v Motole

    RECRUITING

    Prague, Czechia

  • Flinders Medical Centre

    RECRUITING

    Bedford Park, Australia

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    RECRUITING

    Milan, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Rome, Italy

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Xuhui District, China

  • Fujian Cancer Hospital

    RECRUITING

    Fuzhou, China

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto

    RECRUITING

    Sao Jose Rio Preto, Brazil

  • Fundação Champalimaud

    NOT_YET_RECRUITING

    Lisbon, Portugal

  • Fundação Doutor Amaral Carvalho

    RECRUITING

    Jaú, Brazil

  • Gachon University Gil Medical Center

    RECRUITING

    Incheon, 21565, South Korea

  • Gansu Provincial Cancer Hospital

    RECRUITING

    Lanzhou, China

  • General Hospital of Ningxia Medical University

    RECRUITING

    Yinchuan, China

  • GenesisCare North Shore (Oncology)

    RECRUITING

    St Leonards, Australia

  • Gifu University Hospital

    RECRUITING

    Gifu, Japan

  • Goztepe Prof. Dr. Suleyman Yalcin City Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • HCMC Oncology Hospital

    NOT_YET_RECRUITING

    Ho Chi Minh City, Vietnam

  • HCMC University Medical Center

    NOT_YET_RECRUITING

    HoChiMinh, Vietnam

  • Hacettepe University Medical Faculty

    RECRUITING

    Ankara, Turkey (Türkiye)

  • Hanoi Oncology hospital

    RECRUITING

    Hanoi, Vietnam

  • Harbin Medical University Cancer Hospital

    RECRUITING

    Harbin, China

  • Haukeland University Hospital

    RECRUITING

    Bergen, Norway

  • Hiroshima City Hiroshima Citizens Hospital

    RECRUITING

    Hiroshima, Japan

  • Hokkaido University Hospital

    RECRUITING

    Sapporo, 060-8648, Japan

  • Hopital Prive Jean Mermoz

    RECRUITING

    Lyon, France

  • Hopital Rangueil

    RECRUITING

    Toulouse, France

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, Spain

  • Hospital Clinico Universidad de Chile

    NOT_YET_RECRUITING

    Santiago, Chile

  • Hospital Clinico Universitario de Valencia

    RECRUITING

    Valencia, Spain

  • Hospital General Universitario Gregorio Marañon

    RECRUITING

    Madrid, Spain

  • Hospital General Universitario Morales Meseguer

    RECRUITING

    Murcia, Spain

  • Hospital General Universitario de Elche

    RECRUITING

    Elche, Spain

  • Hospital Regional Universitario de Malaga

    RECRUITING

    Málaga, Spain

  • Hospital São Lucas da PUCRS

    RECRUITING

    Porto Alegre, Brazil

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, Spain

  • Hospital Universitario Central de Asturias

    RECRUITING

    Oviedo, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, Spain

  • Hospital Universitario Virgen del Rocio

    RECRUITING

    Seville, Spain

  • Hospital Universitario de Navarra

    RECRUITING

    Pamplona, Spain

  • Hospital da Luz

    RECRUITING

    Lisbon, Portugal

  • Hospital da Senhora da Oliveira Guimarães, E.P.E.

    RECRUITING

    Guimarães, Portugal

  • Hospital das Clínicas FMRP-USP

    RECRUITING

    Ribeirão Preto, Brazil

  • Hospital de Braga

    RECRUITING

    Braga, Portugal

  • Hospital de Clínicas de Porto Alegre

    RECRUITING

    Porto Alegre, Brazil

  • Hospital del Mar

    RECRUITING

    Barcelona, Spain

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, 430079, China

  • Hôpital Européen Georges Pompidou

    RECRUITING

    Paris, France

  • Hôpital Foch

    RECRUITING

    Suresnes, France

  • Hôpital Saint-Antoine

    RECRUITING

    Paris, France

  • ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira Sao Paulo

    RECRUITING

    Brazil, Brazil

  • ICO Badalona - Hospital Universitari Germans Trias i Pujol

    RECRUITING

    Badalona, Spain

  • ICO l'Hospitalet - Hospital Duran i Reynals

    NOT_YET_RECRUITING

    L'Hospitalet de Llobregat, Spain

  • IMIP - Instituto de Medicina Integral Professor Fernando Figueira

    RECRUITING

    Recife, Brazil

  • INCA - Instituto Nacional de Câncer

    RECRUITING

    Rio de Janeiro, Brazil

  • IOV - Istituto Oncologico Veneto IRCCS

    RECRUITING

    Padova, Italy

  • IRCCS Ospedale Casa Sollievo della Sofferenza

    RECRUITING

    San Giovanni Rotondo, Italy

  • IRCCS Ospedale Policlinico San Martino

    RECRUITING

    Genova, Italy

  • Institut Jules Bordet

    RECRUITING

    Anderlecht, Belgium

  • Institut Mutualiste Montsouris

    RECRUITING

    Paris, France

  • Institut Sainte Catherine

    RECRUITING

    Avignon, France

  • Institut de Cancérologie de Strasbourg Europe - ICANS

    RECRUITING

    Strasbourg, France

  • Instituto Medico Especializado Alexander Fleming

    RECRUITING

    Buenos Aires, Argentina

  • Instituto Medico de la Fundacion Estudios Clinicos

    RECRUITING

    Rosario, Argentina

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE

    RECRUITING

    Porto, Portugal

  • Institutul Clinic Fundeni

    RECRUITING

    Bucharest, Romania

  • Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj Napoca

    RECRUITING

    Cluj-Napoca, Romania

  • Institutul Regional de Oncologie Iasi

    RECRUITING

    Iași, Romania

  • Istituto Clinico Humanitas

    RECRUITING

    Rozzano, Italy

  • JCHO Kyushu Hospital

    RECRUITING

    Kitakyushu, 806-0034, Japan

  • Jeonbuk national university hospital

    RECRUITING

    Jeonju, 54907, South Korea

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, 241-8515, Japan

  • Kaohsiung Chang Gung Memorial Hospital

    RECRUITING

    Kaohsiung City, Taiwan

  • Kindai University Hospital

    RECRUITING

    Osakasayama-shi, 589-8511, Japan

  • King Chulalongkorn Memorial Hospital

    RECRUITING

    Pathum Wan, Thailand

  • Klinikum Chemnitz gGmbH

    RECRUITING

    Chemnitz, Germany

  • Klinikum rechts der Isar der TU Muenchen

    RECRUITING

    München, Germany

  • Kochi Health Sciences Center

    RECRUITING

    Kochi, Japan

  • Korea University Anam Hospital

    RECRUITING

    Seoul, 2841, South Korea

  • Kyungpook National University Chilgok Hospital

    RECRUITING

    Daegu, South Korea

  • LKH - Universitaetsklinikum Graz

    RECRUITING

    Graz, Austria

  • Landesklinikum Wiener Neustadt

    RECRUITING

    Wiener Neustadt, Austria

  • Lanzhou University Second Hospital

    NOT_YET_RECRUITING

    Lanzhou, China

  • Liaoning Cancer Hospital & Institute

    RECRUITING

    Shenyang, China

  • Liga Norte-Rio-Grandense Contra o Câncer

    RECRUITING

    Natal, Brazil

  • Linyi Cancer Hospital

    RECRUITING

    Linyi, China

  • MD Anderson Cancer Centre

    RECRUITING

    Madrid, Spain

  • Maryland Oncology Hematology, P.A.

    NOT_YET_RECRUITING

    Silver Spring, Maryland, 20904, United States

  • Masarykuv onkologicky ustav

    RECRUITING

    Brno, Czechia

  • Medical Park Samsun Hastanesi

    NOT_YET_RECRUITING

    Samsun, Turkey (Türkiye)

  • Medical Park Seyhan Hospital

    RECRUITING

    Adana, Turkey (Türkiye)

  • Medipol University Medical Faculty

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • Medisch Centrum Leeuwarden

    RECRUITING

    Leeuwarden, Netherlands

  • Medizinische Universität Innsbruck

    RECRUITING

    Innsbruck, Austria

  • Medizinische Universität Wien

    RECRUITING

    Vienna, Austria

  • Meizhou People's Hospital

    RECRUITING

    Meizhou, China

  • Memorial Sloan Kettering Cancer Center - MAIN

    RECRUITING

    New York, New York, 10065, United States

  • Minnesota Oncology Hematology, P.A.

    WITHDRAWN

    Minneapolis, Minnesota, 55404, United States

  • Miyagi Cancer Center

    RECRUITING

    Natori-shi, Japan

  • Monash Medical Centre Clayton

    RECRUITING

    Clayton, Australia

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10467, United States

  • Mount Sinai Hospital

    NOT_YET_RECRUITING

    Toronto, M5G 1X5, Canada

  • Mount Sinai Hospital

    WITHDRAWN

    Toronto, M5G 1X5, Canada

  • NHO Shikoku Cancer Center

    RECRUITING

    Matsuyama, 791-0280, Japan

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej Curie Panstwowy Instytut Badawczy W Warszawie

    RECRUITING

    Warsaw, Poland

  • National Cancer Center

    RECRUITING

    Goyang-si, South Korea

  • National Cancer Center Hospital

    RECRUITING

    Chūōku, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa-shi, Japan

  • National Cancer Hospital

    RECRUITING

    Hanoi, Vietnam

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, Taiwan

  • National Taiwan University Hospital

    RECRUITING

    Taipei, Taiwan

  • Niigata Cancer Center Hospital

    RECRUITING

    Niigata, 951-8566, Japan

  • Ninewells Hospital

    RECRUITING

    Dundee, United Kingdom

  • Obras Sociais Irmã Dulce - Hospital Santo Antônio

    RECRUITING

    Salvador, Brazil

  • Orchard Healthcare Research Inc.

    RECRUITING

    Skokie, Illinois, 60077, United States

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, 541-8567, Japan

  • Osaka University Hospital

    RECRUITING

    Suita-shi, 565-0871, Japan

  • Oslo Universitetssykehus HF, Ullevål

    RECRUITING

    Oslo, Norway

  • Ospedale San Raffaele

    RECRUITING

    Milan, Italy

  • Peking University Third Hospital

    RECRUITING

    Beijing, 100191, China

  • Penn State University Milton S. Hershey Medical Center

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Peter MacCallum Cancer Centre

    RECRUITING

    North Melbourne, Australia

  • Presidio Ospedaliero Garibaldi Nesima

    RECRUITING

    Catania, Italy

  • Prisma Health Cancer Institute, ITOR, CRU

    RECRUITING

    Greenville, South Carolina, 29605, United States

  • Providence Portland Medical Center

    RECRUITING

    Portland, Oregon, 97213, United States

  • Queen Elizabeth Hospital

    RECRUITING

    Birmingham, United Kingdom

  • Radboudumc

    RECRUITING

    Nijmegen, Netherlands

  • Royal Marsden Hospital

    RECRUITING

    Sutton, United Kingdom

  • S.C Medisprof S.R.L

    RECRUITING

    Cluj-Napoca, Romania

  • S.C Ovidius Clinical Hospital S.R.L

    RECRUITING

    Ovidiu, Romania

  • S.C. Sigmedical Services SRL

    RECRUITING

    Suceava, Romania

  • Samsung Medical Center

    RECRUITING

    Seoul, 6351, South Korea

  • Sarah Cannon Research Institute UK

    RECRUITING

    London, United Kingdom

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam, 13620, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, 3080, South Korea

  • Severance Hospital, Yonsei University Health System

    RECRUITING

    Seoul, 3722, South Korea

  • Shandong Cancer Hospital

    RECRUITING

    Jinan, China

  • Shanxi Provincial Cancer Hospital

    RECRUITING

    Taiyuan, China

  • Shanxi Provincial People's Hospital

    RECRUITING

    Taiyuan, China

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, China

  • Siriraj Hospital

    RECRUITING

    Bangkoknoi, Thailand

  • Songklanagarind Hospital

    RECRUITING

    Hat Yai, Thailand

  • St James's University Hospital

    RECRUITING

    Leeds, United Kingdom

  • St John of God Subiaco Hospital

    RECRUITING

    Subiaco, Australia

  • St. Josef Krankenhaus Wien

    RECRUITING

    Vienna, Austria

  • St. Mary's Hospital

    NOT_YET_RECRUITING

    Montreal, H3T 1M5, Canada

  • St. Olavs Hospital Hf, Universitetssykehuset i Trondheim

    RECRUITING

    Trondheim, Norway

  • Sunnybrook Health Sciences Centre

    RECRUITING

    Toronto, Canada

  • Szpital Wojewodzki im. Mikolaja Kopernika

    RECRUITING

    Koszalin, Poland

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, 112201, Taiwan

  • Tennessee Oncology Nashville Midtown

    WITHDRAWN

    Nashville, Tennessee, 37203, United States

  • Texas Oncology, P.A. - Tyler

    NOT_YET_RECRUITING

    Tyler, Texas, 75702, United States

  • The Affiliated Cancer Hospital of Xinjiang Medical university

    RECRUITING

    Ürümqi, China

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, South Korea

  • The Christie Hospital

    RECRUITING

    Manchester, United Kingdom

  • The First Affiliated Hospital of Xiamen University

    NOT_YET_RECRUITING

    Xiamen, China

  • The First Affiliated Hospital of Xian Jiaotong University

    RECRUITING

    Xi'an, China

  • The First Affiliated Hospital of Zhejiang University school of medicine

    RECRUITING

    Hangzhou, China

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, China

  • The First People's Hospital of Changzhou

    NOT_YET_RECRUITING

    Changzhou, China

  • The Second Affiliated Hospital of Soochow University

    RECRUITING

    Suzhou, China

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, China

  • Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

    RECRUITING

    Bunkyō City, Japan

  • Townsville University Hospital

    RECRUITING

    Douglas, Australia

  • Trillium Health Partners Credit Valley Hospital

    NOT_YET_RECRUITING

    Mississauga, L5M 2N1, Canada

  • Tufts Medical Center

    RECRUITING

    Boston, Massachusetts, 02111, United States

  • UMC Utrecht

    RECRUITING

    Utrecht, Netherlands

  • URUMED Spa

    RECRUITING

    Rancagua, Chile

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75235, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • Unidade Local de Saúde de Santa Maria, E.P.E. - Hospital de Santa Maria

    RECRUITING

    Lisbon, Portugal

  • Universitaetsklinikum Carl Gustav Carus TU Dresden

    RECRUITING

    Dresden, Germany

  • Universitaetsklinikum Frankfurt Goethe-Universitaet

    RECRUITING

    Frankfurt am Main, Germany

  • Universitaetsklinikum Hamburg-Eppendorf

    RECRUITING

    Hamburg, Germany

  • Universitaetsklinikum Heidelberg

    RECRUITING

    Heidelberg, Germany

  • Universitaetsklinikum Leipzig AoeR

    RECRUITING

    Leipzig, Germany

  • University College London Hospitals

    RECRUITING

    London, United Kingdom

  • University Health Network - Princess Margaret Cancer Centre

    NOT_YET_RECRUITING

    Toronto, Canada

  • University of Kansas Medical Center Research Institute, Inc.

    NOT_YET_RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Michigan Comprehensive Cancer Center Michigan Medicine

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Vajira Hospital

    RECRUITING

    Dusit, Thailand

  • Velindre Cancer Centre

    RECRUITING

    Cardiff, United Kingdom

  • Virginia Oncology Associates

    NOT_YET_RECRUITING

    Norfolk, Virginia, 23502-1871, United States

  • Vivantes Klinikum im Friedrichshain

    RECRUITING

    Berlin, Germany

  • Warszawski Uniwersytet Medyczny

    NOT_YET_RECRUITING

    Warsaw, Poland

  • Wenatchee Valley Hospital & Clinics

    WITHDRAWN

    Wenatchee, Washington, 98801, United States

  • Wielkopolskie Centrum Onkologii

    RECRUITING

    Poznan, Poland

  • Wollongong Hospital

    RECRUITING

    Wollongong, Australia

  • Wuxi 4th People's Hospital

    RECRUITING

    Wuxi, China

  • Xuzhou Central Hospital

    RECRUITING

    Xuzhou, China

  • Yale Cancer Center

    NOT_YET_RECRUITING

    New Haven, Connecticut, 06511, United States

  • İ.E.Ü. Medicalpoint İzmir Hastanesi

    WITHDRAWN

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.